ComplianceFeaturesLegal FTC and FDA Issue Warnings to CBD Marketers May 1, 2019 By Ginny Pasqualone In a rare joint sanctions effort, regulators crack down on product claims, just as cannabidiol products take off. Please log in (or register) to continue viewing this content. Username or E-mail Password Remember Me Forgot Password cannabidoilcbdFarm BillFDAFTCGinny PasqualoneKelly Dryeregulation 0 comment 0 Facebook Twitter Google + Pinterest previous post Do Non-Compete and Non-Solicitation Clauses Hold Up in Court? next post Segmenting the Salesforce Related Articles Regulatory Scrutiny Increases January 1, 2020 Industry Grapples with an Identity Crisis November 1, 2018 Do Non-Compete and Non-Solicitation Clauses Hold Up in... May 1, 2019 LOOK FOR OUR DECEMBER ISSUE IN YOUR MAILBOX.... December 1, 2020 Direct Sellers Break into Livestream Shopping June 1, 2021 Special Report: Recognition and Rewards: Direct Selling’s Defining... September 5, 2018 Look for our August issue in your mailbox.... August 1, 2020 FTC Continues Aggressive Stance on Deceptive Claims December 1, 2020 Growth Strategies for 2022 March 1, 2022 Neora Challenges Federal Trade Commission Overreach December 1, 2019
